Skip to main content

Table 1 Summary of primary neuroendocrine carcinoma of the breast cases published in the indexed literature ( n =83) a

From: Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature

      

Neuroendocrine IHC

Hormonal receptors

 

Treatment

  

Author (year) [Ref]

Age (years)/Sex

Site

Size (cm)b

TNM

IS

GML

NSE

CgA/B

Syn

NSG

ER

PR

HER2/Neu

Neoadjuvant

Surgical

Adjuvant

Follow-up (months)

Outcome

Wade (1983) [18]

52/F

R

10.0

T4N1M0

-

-

   

+

NS

NS

NS

NS

Mast/ALND

Ch

9

DOD

Jundt (1984) [16]

52/M

R

NS

TxN1M0

NS

-

+

  

+

NS

NS

NS

NS

NS

Ch/RT

14

DOD

Papotti (1992) [19]

64/F

R

2.0

T1N0M0

+

-

-

-

-

 

-

NS

NS

NS

Mast/ALND

NS

44

NED

41/F

L

3.5

T2NxM0

+

-

+

-

-

+

-

NS

NS

NS

Mast/ALND

RT

15

DOD

41/F

L

3.0

T2NxM0

+

+

+

+

+

+

-

NS

NS

NS

Mast/ALND

Ch

14

LR/DOD

69/F

L

5.0

T3NxM0

+

+

+

-

+

 

+

NS

NS

NS

Mast/ALND

HT

9

DOD

Papotti (1993) [17]

83/M

R

1.5

T1N0M0

+

+

+

+

  

-

NS

NS

NS

Mast

NS

84

DOD

Francois (1995) [20]

68/F

R

4.5

T2N0M0

NS

  

+

  

-

-

NS

-

Mast/ALND

RT

21

D-NOS

Chua (1997) [21]

45/F

L

NS

T2N0Mx

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

BCS

NS

NS

NS

Fukunaga (1998) [22]

56/F

R

10.0

T3NxM0

+

  

+

+

 

-

-

NS

-

Mast/ALND

-

48

NED

Samli (2000) [23]

60/F

L

8.0

T4N1M0

NS

  

+

+

 

NS

NS

NS

Ch

Mast/ALND

Ch/RT

6

LR

Shin (2000) [24]

43/F

R

1.3

T1NxM0

NS

 

+

   

NS

NS

-

-

BCS

RT

30

NED

44/F

L

2.0

T1NxM0

NS

 

+

   

NS

NS

-

-

BCS/ALND

Ch/RT

27

NED

46/F

R

3.4

T2NxM0

NS

 

+

   

NS

NS

-

-

Mast/ALND

Ch

11

AWM

50/F

R

2.2

T2NxM0

+

 

+

   

NS

NS

-

-

BCS/ALND

Ch/HT

35

NED

51/F

R

1.5

T1NxM0

NS

 

+

   

NS

NS

-

-

BCS/ALND

RT

25

NED

57/F

L

2.5

T2NxM0

NS

 

+

   

NS

NS

-

-

Mast/ALND

Ch

10

NED

62/F

L

5.0

T3NxM0

+

 

+

   

NS

NS

-

Ch

Mast/ALND

Ch/HT

32

AWM

64/F

L

1.8

T1NxM0

NS

 

+

   

NS

NS

-

-

BCS/ALND

Ch

10

NED

70/F

L

4.0

T2NxM0

+

 

+

   

NS

NS

-

-

BCS/ALND

Ch/RT

3

NED

Yamasaki (2000) [25]

41/F

R

4.5

T2N0M0

+

  

+

  

-

NS

NS

-

BCS/Mast/ALND

Ch

16

NED

Salmo (2001) [26]

46/F

R

4.0

T2N0M0

+

+

NS

NS

NS

NS

-

+

NS

-

BCS

Ch/RT

9

NED

Zekioglu (2003) [27]

79/F

R

1.5

T1N0M0

+

 

+

+

-

 

+

+

NS

NS

Mast/ALND

NS

24

NED

76/F

L

2.2

T2N0M0

+

 

+

+

+

 

+

+

NS

NS

BCS

NS

18

NED

65/F

R

3.5

T2N0M0

+

 

+

-

+

 

+

+

NS

NS

Mast/ALND

NS

16

NED

68/F

R

7.0

T3N1M0

+

 

+

+

+

 

-

-

NS

NS

Mast/ALND

NS

22

NED

69/F

R

1.0

T1N0M0

+

 

+

+

+

 

+

+

NS

NS

Mast/ALND

NS

12

NED

72/F

R

1.5

T1N0M0

+

 

+

-

+

 

+

+

NS

NS

BCS

NS

13

NED

60/F

R

1.0

T1N0M0

+

 

+

+

+

 

+

+

NS

NS

BCS

NS

10

NED

43/F

L

0.8

T1N0M0

+

 

+

-

+

 

+

+

NS

NS

BCS

NS

48

NED

60/F

L

2.5

T2N0M0

+

 

+

-

+

 

+

+

NS

NS

Mast/ALND

NS

54

NED

43/F

L

5.0

T2N0M0

+

 

+

-

+

 

+

+

NS

NS

BCS

NS

NS

NED

72/F

L

2.7

T2N0M0

+

 

+

-

+

 

+

+

NS

NS

BCS

NS

NS

NED

72/F

L

2.7

T2N0M0

+

 

+

-

+

 

+

+

NS

NS

Mast/ALND

NS

NS

NED

Bergman (2004) [28]

61/F

L

2.5

T2NxM0

+

 

+

-

-

 

-

-

-

-

Mast/ALND

NS

NS

NS

Bigotti (2004) [29]

56/F

L

18.0

T3N1M0

+

 

+

-

+

 

-

-

-

Ch

Mast

Ch

14

D-N0S

Jochems (2004) [30]

71/F

NS

3.0

T2NxM0

NS

 

+

+

+

 

+

+

-

-

Mast/ALND

HT

12

NED

Sridhar (2004) [31]

58/F

R

2.0

T1NxM0

NS

  

-

  

-

-

NS

-

BCS/ALND

Ch/RT

18

NED

Yamamoto (2004) [32]

53/F

NS

6.5

T3N2M0

NS

 

+

   

NS

NS

NS

NS

NS

NS

34

NED

75/F

NS

2.0

T2N1M0

NS

 

+

   

NS

NS

NS

NS

NS

NS

43

NED

Berruti (2004) [33]

59/F

NS

NS

T2N0M0

+

 

+

+

+

 

+

-

NS

-

Mast

HT

NS

AWM

Adegbola (2005) [34]

46/F

R

1.0

T1N0M0

NS

  

+

+

 

-

-

-

-

BCS

Ch/RT

48

NED

60/F

R

1.7

T1NxM0

+

  

+

+

 

-

-

-

-

BCS

Ch/RT

20

D-NOS

61/F

L

1.7

T1NxM0

NS

  

+

  

-

-

-

-

BCS

Ch/RT

6

AWM

Valdes (2006) [35]

41/F

R/MF

1.5

T1NxM0

+

   

+

 

-

-

NS

-

Mast/SLNB/Re

Ch

NS

NS

Fujimoto (2007) [36]

40/F

L/MF

2.0

T1NxM0

+

  

+

+

 

+

+

+

-

Mast/SLNB

HT

36

NED

Kim (2008) [37]

27/F

L

3.2

T2NxM0

NS

 

+

+

+

 

NS

NS

NS

-

BCS/ALND

Ch/RT

18

NED

Kinoshita (2008) [9]

31/F

L

6.0

T3NxM0

+

 

+

+

  

-

-

-

Ch

Mast/ALND

Ch

9

D-NOS

Stita (2009) [38]

64/F

L

3.0

T2NxM0

+

 

+

+

  

+

+

NS

-

Mast/ALND

Ch

8

NED

Yamaguchi (2009) [39]

51/F

R

3.0

T2NxM0

NS

  

+

+

 

-

-

-

-

Mast/ALND

Ch

12

AWM

Christie (2010) [40]

61/F

L

3.0

T2NxM0

+

  

+

+

 

-

-

-

-

BCS/ALND

Ch

3

D-NOS

Latif (2010) [41]

53 /F

R

6.0

T3N0M0

NS

  

+

+

 

-

-

-

Ch

BCS/SLNB

RT

NS

NS

Honami (2011) [42]

54/F

B

L: 1.0

T1N0M0

L: +

  

+

+

 

+

+

-

-

BCS

RT

18

NED

R: 1.5

R: +

Kawanishi (2011) [43]

67/F

R

0.8

T1NxM0

+

  

+

+

 

+

+

-

-

BCS/ SLNB

HT

12

NED

Nozoe (2011) [44]

57/F

R

3.0

T2NxM0

NS

 

+

 

+

 

+

+

-

-

Mast/ALND

Ch

NS

NS

Zhang (2011) [45]

29/F

B

L: 8.5

T1N2M0

L: +

 

+

+

+

 

+

+

-

-

BCS

Ch

NS

NS

R: 2.0

R: +

Su (2012) [46]

75/F

L

4.0

T2N0M0

NS

  

+

+

 

+

+

-

-

Mast/ALND

HT

20

NED

Miura (2012) [47]

72/F

R/MC

1.5

T1N0M0

Both +

  

+

+

 

+

+

-

NS

Mast/SLNB

NS

NS

NS

Kawasaki (2012) [48]

41/F

L

0.0

TisN0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

101

NED

45/F

R

0.0

TisN0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

80

NED

41/F

L

0.0

TisN0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

90

NED

74/F

R

0.0

TisN0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

91

NED

28/F

R

0.0

TisN0M0

+

  

+

+

 

+

+

NS

NS

Mast

NS

77

NED

30/F

L

0.0

TisN0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

86

NED

58/F

R

0.0

TisN0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

96

NED

36/F

L

0.0

TisN0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

64

NED

38/F

R

0.0

TisN0M0

+

  

+

+

 

+

+

NS

NS

Mast

NS

69

NED

60/F

L

0.1

T1N0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

84

NED

42/F

L

0.1

T1N0M0

+

  

+

+

 

+

+

NS

NS

Mast

NS

73

NED

43/F

R

0.1

T1N0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

80

NED

35/F

R

0.1

T1N0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

100

NED

70/F

L

0.1

T1N0M0

+

  

+

+

 

+

+

NS

NS

Mast

NS

93

NED

72/F

R

0.1

T1N0M0

+

  

+

+

 

+

+

NS

NS

Mast

NS

66

NED

62/F

L

0.1

T1N0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

88

NED

38/F

R

0.2

T1N0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

85

NED

73/F

R

0.3

T1N0M0

+

  

+

+

 

+

+

NS

NS

Mast

NS

71

NED

43/F

L

0.4

T1N1M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

86

NED

42/F

L

0.5

T1N0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

96

NED

39/F

R

0.5

T1N0M0

+

  

+

+

 

+

+

NS

NS

Mast

NS

74

NED

33/F

R

0.7

T1N0M0

+

  

+

+

 

+

+

NS

NS

Mast

NS

92

NED

36/F

L

1.5

T1N0M0

+

  

+

+

 

+

+

NS

NS

BCS

NS

99

NED

68/F

R

2.5

T2N0M0

+

  

+

+

 

+

+

NS

NS

Mast

NS

68

NED

(2012) [Present case]

51/F

R

2.0

T4aN0M0

+

  

+

+

 

+

-

-

Ch/RT

Mast/ALND

Ch/HT

13

AWM

  1. aStudies included in this table are those available in PubMed as of May 31, 2012. Papers that were excluded from this summary are those in which information was not provided explicitly in the description of the case report or because the results were grouped into cohorts [12, 49, 57].
  2. bObtained either from clinical history or the final pathology report; for multifocal or multicentric disease the largest tumor was registered.
  3. ALND, axillary lymph node dissection; AWM, alive with metastatic disease; B, bilateral; BCS, breast conserving surgery; CgA/B, chromogranin A and/or B; Ch, chemotherapy; D-NOS, dead, but cause not otherwise specified; DOD, dead of other disease; ER, estrogen receptors; F, female; GML, Grimelius staining; HT, hormone therapy; IHC, immunohistochemistry; IS, breast in situ component; LR, local recurrence; M, male; Mast, mastectomy; MC, multicentric; MF, multifocal; NED; no evidence of disease; NS, information not specified; NSE, neuron-specific enolase; NSG, neurosecretory granules; PR, progesterone receptors; R, right; Re, reconstruction; RT, radiation therapy; SLNB, sentinel lymph node biopsy; Syn, synaptophysin.